Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,484 hedge funds and large institutions have $92.1B invested in Celgene Corp in 2017 Q3 according to their latest regulatory filings, with 122 funds opening new positions, 581 increasing their positions, 578 reducing their positions, and 52 closing their positions.
135% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 52
17% more funds holding in top 10
Funds holding in top 10: 128 → 150 (+22)
13% more capital invested
Capital invested by funds: $81.5B → $92.1B (+$10.6B)
4% more funds holding
Funds holding: 1,428 → 1,484 (+56)
1% more repeat investments, than reductions
Existing positions increased: 581 | Existing positions reduced: 578
2% less call options, than puts
Call options by funds: $1.49B | Put options by funds: $1.52B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$646M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$428M |
| 3 |
Jennison Associates
New York
|
+$211M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$189M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$156M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$364M |
| 2 |
HM
HealthCor Management
New York
|
-$188M |
| 3 |
BlackRock
New York
|
-$171M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$165M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$157M |
CELG Hedge Fund Activity: Q3 2017 in Review
1,484 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2017, worth a combined $92.1B — up 13% from $81.5B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new CELG positions and 52 closed out — a net gain of 70 holders — while 581 added to existing stakes and 578 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $646M. The largest seller was Amundi Asset Management US, cutting an estimated $364M.
- 1,484 institutional investors held Celgene Corp (CELG) as of Q3 2017, up from 1,428 in Q2 2017.
- Funds reported $92.1B of Celgene Corp stock for Q3 2017, up 13% quarter-over-quarter.
- 122 funds opened new Celgene Corp positions in Q3 2017 and 52 closed out, a net change of +70 holders.
- The largest Celgene Corp buyer in Q3 2017 was Fidelity Investments, an estimated $646M added.
- The largest Celgene Corp seller in Q3 2017 was Amundi Asset Management US, an estimated $364M sold.
Based on aggregated 13F filings for Q3 2017.